Yabao Pharmaceutical Group Co Ltd (600351) — Financial Flexibility Index
Yabao Pharmaceutical Group Co Ltd (600351) has a Financial Flexibility Index of 0.23x as of September 2025. Free cash flow of CN¥137.07 Million (operating CF CN¥129.49 Million minus capex CN¥7.58 Million) represents 0% of total liabilities (CN¥585.77 Million). Check 600351 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Yabao Pharmaceutical Group Co Ltd Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for Yabao Pharmaceutical Group Co Ltd across 24 annual periods. See working capital to net assets of Yabao Pharmaceutical Group Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year free cash flow to debt coverage for Yabao Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see 600351 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.78x | CN¥506.36 Million | CN¥471.69 Million | CN¥649.02 Million | ▲ +12.4% |
| 2023 | 0.69x | CN¥597.41 Million | CN¥497.55 Million | CN¥860.33 Million | ▲ +49.4% |
| 2022 | 0.46x | CN¥522.69 Million | CN¥460.46 Million | CN¥1.12 Billion | ▼ -2.8% |
| 2021 | 0.48x | CN¥532.56 Million | CN¥437.50 Million | CN¥1.11 Billion | ▲ +28.9% |
| 2020 | 0.37x | CN¥443.83 Million | CN¥380.96 Million | CN¥1.20 Billion | ▲ +1.2% |
| 2019 | 0.37x | CN¥582.26 Million | CN¥425.17 Million | CN¥1.59 Billion | ▲ +34.4% |
| 2018 | 0.27x | CN¥494.61 Million | CN¥426.60 Million | CN¥1.81 Billion | ▲ +51.9% |
| 2017 | 0.18x | CN¥261.07 Million | CN¥161.73 Million | CN¥1.45 Billion | ▲ +10.2% |
| 2016 | 0.16x | CN¥240.42 Million | CN¥155.95 Million | CN¥1.48 Billion | ▲ +4.6% |
| 2015 | 0.16x | CN¥245.14 Million | CN¥143.47 Million | CN¥1.57 Billion | ▼ -39.7% |
| 2014 | 0.26x | CN¥352.47 Million | CN¥178.63 Million | CN¥1.37 Billion | ▲ +149.6% |
| 2013 | 0.10x | CN¥155.82 Million | CN¥56.80 Million | CN¥1.51 Billion | ▲ +1383.4% |
| 2012 | 0.01x | CN¥8.85 Million | CN¥-96.73 Million | CN¥1.27 Billion | ▼ -95.2% |
| 2011 | 0.14x | CN¥160.28 Million | CN¥40.73 Million | CN¥1.11 Billion | ▲ +0.1% |
| 2010 | 0.14x | CN¥205.87 Million | CN¥18.57 Million | CN¥1.43 Billion | ▼ -70.4% |
| 2009 | 0.49x | CN¥638.39 Million | CN¥368.56 Million | CN¥1.31 Billion | ▲ +64.1% |
| 2008 | 0.30x | CN¥250.46 Million | CN¥102.90 Million | CN¥843.93 Million | ▲ +50.4% |
| 2007 | 0.20x | CN¥136.99 Million | CN¥105.69 Million | CN¥694.23 Million | ▲ +141.2% |
| 2006 | 0.08x | CN¥55.29 Million | CN¥11.59 Million | CN¥675.74 Million | ▼ -52.8% |
| 2005 | 0.17x | CN¥135.35 Million | CN¥26.40 Million | CN¥780.42 Million | ▼ -63.2% |
| 2004 | 0.47x | CN¥282.54 Million | CN¥79.73 Million | CN¥599.65 Million | ▲ +122.1% |
| 2003 | 0.21x | CN¥73.55 Million | CN¥-9.62 Million | CN¥346.67 Million | ▼ -30.4% |
| 2002 | 0.30x | CN¥51.67 Million | CN¥24.29 Million | CN¥169.57 Million | ▲ +10.8% |
| 2001 | 0.27x | CN¥46.63 Million | CN¥23.59 Million | CN¥169.58 Million | — |